Literature DB >> 23766529

Kupffer cells potentiate liver sinusoidal endothelial cell injury in sepsis by ligating programmed cell death ligand-1.

Noelle A Hutchins1, Fei Wang, Yvonne Wang, Chun-Shiang Chung, Alfred Ayala.   

Abstract

PD-1 and PD-L1 have been reported to provide peripheral tolerance by inhibiting TCR-mediated activation. We have reported that PD-L1-/- animals are protected from sepsis-induced mortality and immune suppression. Whereas studies indicate that LSECs normally express PD-L1, which is also thought to maintain local immune liver tolerance by ligating the receptor PD-1 on T lymphocytes, the role of PD-L1 in the septic liver remains unknown. Thus, we hypothesized initially that PD-L1 expression on LSECs protects them from sepsis-induced injury. We noted that the increased vascular permeability and pSTAT3 protein expression in whole liver from septic animals were attenuated in the absence of PD-L1. Isolated LSECs taken from septic animals, which exhibited increased cell death, declining cell numbers, reduced cellular proliferation, and VEGFR2 expression (an angiogenesis marker), also showed improved cell numbers, proliferation, and percent VEGFR2(+) levels in the absence of PD-L1. We also observed that sepsis induced an increase of liver F4/80(+)PD-1(+)-expressing KCs and increased PD-L1 expression on LSECs. Interestingly, PD-L1 expression levels on LSECs decreased when PD-1(+)-expressing KCs were depleted with clodronate liposomes. Contrary to our original hypothesis, we document here that increased interactions between PD-1(+) KCs and PD-L1(+) LSECs appear to lead to the decline of normal endothelial function-essential to sustain vascular integrity and prevent ALF. Importantly, we uncover an underappreciated pathological aspect of PD-1:PD-L1 ligation during inflammation that is independent of its normal, immune-suppressive activity.

Entities:  

Keywords:  acute liver failure; coinhibitory molecules; hepatic endothelium; liver immune tolerance; septic inflammation

Mesh:

Substances:

Year:  2013        PMID: 23766529      PMCID: PMC3800070          DOI: 10.1189/jlb.0113051

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  56 in total

1.  Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance.

Authors:  A Limmer; J Ohl; C Kurts; H G Ljunggren; Y Reiss; M Groettrup; F Momburg; B Arnold; P A Knolle
Journal:  Nat Med       Date:  2000-12       Impact factor: 53.440

Review 2.  The Fas signaling pathway: more than a paradigm.

Authors:  Harald Wajant
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

Review 3.  The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome.

Authors:  William C Aird
Journal:  Blood       Date:  2003-01-23       Impact factor: 22.113

4.  PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells.

Authors:  P'ng Loke; James P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-15       Impact factor: 11.205

5.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

6.  Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis.

Authors:  Nancy Rodig; Timothy Ryan; Jessica A Allen; Hong Pang; Nir Grabie; Tatyana Chernova; Edward A Greenfield; Spencer C Liang; Arlene H Sharpe; Andrew H Lichtman; Gordon J Freeman
Journal:  Eur J Immunol       Date:  2003-11       Impact factor: 5.532

7.  Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.

Authors:  Haidong Dong; Scott E Strome; Diva R Salomao; Hideto Tamura; Fumiya Hirano; Dallas B Flies; Patrick C Roche; Jun Lu; Gefeng Zhu; Koji Tamada; Vanda A Lennon; Esteban Celis; Lieping Chen
Journal:  Nat Med       Date:  2002-06-24       Impact factor: 53.440

8.  Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms.

Authors:  Sanae Haga; Keita Terui; Hui Qi Zhang; Shin Enosawa; Wataru Ogawa; Hiroshi Inoue; Torayuki Okuyama; Kiyoshi Takeda; Shizuo Akira; Tetsuya Ogino; Kaikobad Irani; Michitaka Ozaki
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

9.  Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.

Authors:  G J Freeman; A J Long; Y Iwai; K Bourque; T Chernova; H Nishimura; L J Fitz; N Malenkovich; T Okazaki; M C Byrne; H F Horton; L Fouser; L Carter; V Ling; M R Bowman; B M Carreno; M Collins; C R Wood; T Honjo
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

10.  PD-1 inhibits antiviral immunity at the effector phase in the liver.

Authors:  Yoshiko Iwai; Seigo Terawaki; Masaya Ikegawa; Taku Okazaki; Tasuku Honjo
Journal:  J Exp Med       Date:  2003-07-07       Impact factor: 14.307

View more
  24 in total

1.  A novel role for programmed cell death receptor ligand 2 in sepsis-induced hepatic dysfunction.

Authors:  Anne-Lise Rossi; Marilyn Le; Chun-Shiang Chung; Yaping Chen; Eleanor A Fallon; Andres Matoso; Shumin Xu; Tristen T Chun; Craig P Erickson; Alfred Ayala
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-11-15       Impact factor: 4.052

Review 2.  New aspects of hepatic endothelial cells in physiology and nonalcoholic fatty liver disease.

Authors:  Xinghui Sun; Edward N Harris
Journal:  Am J Physiol Cell Physiol       Date:  2020-05-06       Impact factor: 4.249

3.  NF-κB RelA Is Required for Hepatoprotection during Pneumonia and Sepsis.

Authors:  Yuri Kim; Eri Allen; Lillia A Baird; Elise M Symer; Filiz T Korkmaz; Elim Na; Christine V Odom; Matthew R Jones; Joseph P Mizgerd; Katrina E Traber; Lee J Quinton
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

Review 4.  The new normal: immunomodulatory agents against sepsis immune suppression.

Authors:  Noelle A Hutchins; Jacqueline Unsinger; Richard S Hotchkiss; Alfred Ayala
Journal:  Trends Mol Med       Date:  2014-01-30       Impact factor: 11.951

Review 5.  Immunotherapy for solid tumors--a review for surgeons.

Authors:  Abdul Saied; Venu G Pillarisetty; Steven C Katz
Journal:  J Surg Res       Date:  2013-12-25       Impact factor: 2.192

6.  Roflumilast reverses polymicrobial sepsis-induced liver damage by inhibiting inflammation in mice.

Authors:  Hongfang Feng; Jiajia Chen; Haitao Wang; Yufang Cheng; Zhengqiang Zou; Qiuping Zhong; Jiangping Xu
Journal:  Lab Invest       Date:  2017-06-26       Impact factor: 5.662

Review 7.  The role of liver sinusoidal endothelial cells in cancer liver metastasis.

Authors:  Ming Yang; Chunye Zhang
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

8.  Programmed cell death receptor ligand 1 modulates the regulatory T cells' capacity to repress shock/sepsis-induced indirect acute lung injury by recruiting phosphatase SRC homology region 2 domain-containing phosphatase 1.

Authors:  Lunxian Tang; Jianwen Bai; Chun-Shiang Chung; Joanne Lomas-Neira; Yaping Chen; Xin Huang; Alfred Ayala
Journal:  Shock       Date:  2015-01       Impact factor: 3.454

9.  Contribution of programmed cell death receptor (PD)-1 to Kupffer cell dysfunction in murine polymicrobial sepsis.

Authors:  Fei Wang; Xin Huang; Chun-Shiang Chung; Yaping Chen; Noelle A Hutchins; Alfred Ayala
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-06-10       Impact factor: 4.052

Review 10.  PD-1 immunobiology in autoimmune hepatitis and hepatocellular carcinoma.

Authors:  Colleen S Curran; Elad Sharon
Journal:  Semin Oncol       Date:  2018-01-06       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.